IDEAYA is an oncology-focused precision medicine company. Our teams are committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. We are advancing therapeutics that have the potential to be first-in-class and/or best-in-class, with a primary focus in synthetic lethality – an emerging class of precision medicine targets. IDEAYA is headquartered in South San Francisco, California

Pharmaceutical

IDEAYA Biosciences

Yujiro S. Hata

Senior Vice President, Chief General Counsel

Daniel Simon

Andres Ruiz Briseno

Claire L. Neilan

Jasgit Sachdev

Paul A. Barsanti

Michael White

Darrin M. Beaupre

Mick O’Quigley

The Scientific and Research Team at IDEAYA Biosciences is dedicated to the discovery and development of targeted cancer therapies through precision medicine. This team leverages molecular diagnostics to identify patient populations that can benefit from novel treatments, with a key focus on synthetic lethality. They are responsible for advancing first-in-class and best-in-class therapeutic candidates by conducting cutting-edge research and generating crucial biomarkers to support clinical development efforts.

Scientific and Research Team

Leadership Team

Clinical Development Team

Scientific and Research Team

About

Team members

Other teams at IDEAYA Biosciences

Leadership Team

Clinical Development Team